492: Moving Finance to the Center | David Evans, CFO, Cardlytics
It wasn't long after David Evans arrived inside the CFO office at Cardlytics that finance team members learned that their office surroundings were about to change. Originally domiciled in the less-trafficked--some would say "quiet"--side of the building, Evans wasted little time in relocating his team to more central (and arguably more social) office space. "Physically…
Listen to the Episode Below (00:38:03)
491: When the Virtues of Organic Growth Trump M&A | Arthur Levine, CFO, Sensus Healthcare
Back in 2014, shortly after Arthur Levine first stepped into the CFO office at Sensus Healthcare, the fast-growing medical device company hit a sizable speed bump. A growing number of future Sensus customers were putting their purchases on hold as uncertainty around insurance reimbursements grew in relation to a review being conducted by The Centers…
Listen to the Episode Below (00:35:52)
When Finance Is “The Octopus” | Mark Patrick, CFO, Syngenta, AG
CFOTL: How do you view the role of finance in this organization? Patrick: We’re like the octopus. We have the tentacles that go into every part of the organization, and it all comes back to finance at the end of the day. We have to have an element of independence, a challenge, a role within…
490: Telling Your Story in Real Time | Craig Nickerson, CFO, insightsoftware
When it comes to newbie accountants, few clients are more coveted within the realm of public accounting than those preparing for an IPO. So it was back in the early 1990s, when Craig Nickerson found himself knee-deep in CPA envy after having served not one but five of his firm's IPO-minded tech clients. Today, Nickerson…
Listen to the Episode Below (00:47:20)
489: The Elements of Transformation | Ted Myles, CFO, AMAG Pharmaceuticals
When Ted Myles is asked to reflect back on his early efforts to land a CFO role, he arguably sounds a little bit like a safecracker. "Breaking into the C-suite that first time is always hard," he explains. "I went in and would continue to get beat out by a sitting CFO. Understandably: A board…
Listen to the Episode Below (00:45:04)
488: When Shareholder Dividends Equal Fewer Going Hungry | Chris Whitfield, CFO, MANA Nutrition
From the moment Chris Whitfield stepped into the CFO office at MANA Nutrition, it was clear to him that various snags in the organization’s information flows were keeping the not-for-profit’s board members on edge. To remedy the situation, Whitfield reformulated the not-for-profit’s approach to reporting, beginning with a beefier balance sheet instead of the slimmed…
Listen to the Episode Below (00:44:51)
487: Putting Your Organization on an Even Keel | Robin Gantt, CFO, Northwest Pipe Company
It's unlikely that this is the first sentence ever to include the phrase "even-keeled" alongside the name Robin Gantt, but this is a pairing that bears repeating here to reveal not only an obvious character trait of our latest guest, but also one that frequently sets apart CFO leadership at large. Gantt, already a seasoned…
Listen to the Episode Below (00:35:53)
486: Counting Your Customer Success Milestones | Matthew Fahy, CFO, FinFit
When Matt Fahy identifies the opportunities that have punctuated his finance career, he credits subscription revenue models as having played a recurring role along the trajectory that has led to multiple CFO tours of duty. For Fahy, it all began with a move to New York City, where he was soon serving one of the…
Listen to the Episode Below (00:46:46)
485: Finding a Cure for the IPO Blues | Mark Lee, CFO, Forge
Before joining Goldman Sachs back in the late 1980s, Mark Lee was a finance manager at Hewlett-Packard Co. Today, Lee fondly recalls being mentored by a senior controller while situated deep inside the technology behemoth's computer support division. The finance executive, explains Lee, viewed controllership as a strategic role where executives could acquire and build their…
Listen to the Episode Below (00:35:58)
484: Milestones for a CFO Barn Raiser | Andrew Guggenhime, CFO, Dermira
When asked about his arrival at Dermira, CFO Andrew Guggenhime explains: "I was the 22nd employee, and today we have over 300." Along the way, the company executed an IPO, reached a market value of $1 billion, received FDA approval for its first medication (last June), and brought the offering to market (last October). Not…
Listen to the Episode Below (00:29:59)
Other Podcasts From Middle-Market Media
